Erasca, Inc. · NASDAQ:ERAS
Novartis Pharma AG's stake in Erasca, Inc. fell to 4.40% (Schedule 13G/A)
Event Dec 31, 2024 · Filed Feb 12, 2025
Novartis Pharma AG's stake in Erasca, Inc. fell to 4.40%, 12,307,692 shares, as a passive investor on Dec 31, 2024. Filed Feb 12, 2025 (Schedule 13G/A).
- Stake
- 4.40%
- Shares
- 12,307,692
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Novartis Pharma AG | 4.40% | 12,307,692 |
| Novartis AG | 4.40% | 12,307,692 |
Source
Related
- Erasca, Inc.
- Novartis Pharma AG
- Erasca, Inc. shareholders
- Schedule 13G/A · Jonathan E. Lim · Aug 14, 2026
- Schedule 13G/A · Paradigm Biocapital Advisors LP · May 15, 2026
- Schedule 13G · Rtw Investments, LP · May 15, 2026
- Schedule 13G/A · Venrock Healthcare Capital Partners III, L.P. · May 15, 2026
- Schedule 13G/A · T. Rowe Price Investment Management, Inc. · May 15, 2026